Cargando…

Association of inflammatory markers with the severity of COVID-19: A meta-analysis

OBJECTIVES: Studies reported associations of inflammatory markers with the severity of COVID-19, but conclusions were inconsistent. We aimed to provide an overview of the association of inflammatory markers with the severity of COVID-19. METHODS: We searched PubMed, Embase, Cochrane Library, Wanfang...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Furong, Huang, Yuzhao, Guo, Ying, Yin, Mingzhu, Chen, Xiang, Xiao, Liang, Deng, Guangtong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233226/ https://www.ncbi.nlm.nih.gov/pubmed/32425643 http://dx.doi.org/10.1016/j.ijid.2020.05.055

Ejemplares similares

Clinical determinants for fatality of 44,672 patients with COVID-19
por: Deng, Guangtong, et al.
Publicado: (2020)

Characteristics of pregnant patients with COVID-19 and liver injury
por: Deng, Guangtong, et al.
Publicado: (2020)

Convalescent plasma for patients with COVID-19
por: Zeng, Furong, et al.
Publicado: (2020)

Commentary on: Nomograms based on inflammatory biomarkers for predicting tumor grade and microvascular invasion in stage I/II hepatocellular carcinoma
por: Xiao, Liang, et al.
Publicado: (2019)

A novel predictive model incorporating immune-related gene signatures for overall survival in melanoma patients
por: Liao, Mengting, et al.
Publicado: (2020)

Serological response following COVID-19 vaccines in patients living with HIV: a dose–response meta-analysis
por: Zhou, Qian, et al.
Publicado: (2023)

A predictive model for the severity of COVID-19 in elderly patients
por: Zeng, Furong, et al.
Publicado: (2020)

BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression
por: Zeng, Furong, et al.
Publicado: (2023)

Correlation between CD4 T-Cell Counts and Seroconversion among COVID-19 Vaccinated Patients with HIV: A Meta-Analysis
por: Zhou, Qian, et al.
Publicado: (2023)

Risk and outcomes of breakthrough COVID‐19 infections in vaccinated immunocompromised patients: A meta‐analysis
por: Deng, Guangtong, et al.
Publicado: (2023)

The anti-ferroptotic role of FSP1: current molecular mechanism and therapeutic approach
por: Zeng, Furong, et al.
Publicado: (2022)

BET inhibitor suppresses melanoma progression via the noncanonical NF-κB/SPP1 pathway
por: Deng, Guangtong, et al.
Publicado: (2020)

Clinical Significance of Plasma D-Dimer in COVID-19 Mortality
por: Li, Yayun, et al.
Publicado: (2021)

Azvudine versus Paxlovid for oral treatment of COVID-19 in Chinese patients with pre-existing comorbidities
por: Dian, Yating, et al.
Publicado: (2023)

The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis
por: Chen, Yi, et al.
Publicado: (2020)

Nomogram based on inflammatory indices for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma
por: Chen, Lang, et al.
Publicado: (2020)

Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study
por: Sun, Yuming, et al.
Publicado: (2023)

EEF2K silencing inhibits tumour progression through repressing SPP1 and synergises with BET inhibitors in melanoma
por: Deng, Guangtong, et al.
Publicado: (2022)

Elevated troponin levels predict the reduced efficacy of Paxlovid in COVID-19 patients
por: Zhao, Deze, et al.
Publicado: (2023)

Prognostic value of liver biochemical parameters for COVID-19 mortality
por: Ye, Lin, et al.
Publicado: (2021)

Nomogram For Preoperative Prediction Of Microvascular Invasion Risk In Hepatocellular Carcinoma
por: Deng, Guangtong, et al.
Publicado: (2019)

Corrigendum to ‘Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study.’ [EClinicalMedicine 59 (2023) 101981]
por: Sun, Yuming, et al.
Publicado: (2023)

Tumor neutrophils ferroptosis: a targetable immunosuppressive mechanism for cancer immunotherapy
por: Du, Songtao, et al.
Publicado: (2023)

Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients
por: Du, Songtao, et al.
Publicado: (2022)

Prognostic Implications of Metabolism Related Gene Signature in Cutaneous Melanoma
por: Zeng, Furong, et al.
Publicado: (2020)

WeChat: a new clinical teaching tool for problem-based learning
por: Zeng, Furong, et al.
Publicado: (2016)

Nomogram based on autophagy related genes for predicting the survival in melanoma
por: Deng, Guangtong, et al.
Publicado: (2021)

Association of elevated inflammatory markers and severe COVID-19: A meta-analysis
por: Ji, Pan, et al.
Publicado: (2020)

Macrophage activation syndrome and pulmonary arterial hypertension in a patient with adult-onset Still disease: A case report
por: Zeng, Furong, et al.
Publicado: (2019)

The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving Immunotherapy
por: Li, Yayun, et al.
Publicado: (2022)

Cardiac markers of multisystem inflammatory syndrome in children (MIS-C) in COVID-19 patients: A meta-analysis
por: Zhao, Yan, et al.
Publicado: (2021)

Strategies for improvement of WeChat-PBL teaching: experience from China
por: Zeng, Furong, et al.
Publicado: (2016)

Targeting Ferroptosis by Ubiquitin System Enzymes: A Potential Therapeutic Strategy in Cancer
por: Meng, Yu, et al.
Publicado: (2022)

Inhibiting SCD expression by IGF1R during lorlatinib therapy sensitizes melanoma to ferroptosis
por: Zeng, Furong, et al.
Publicado: (2023)

Inflammatory markers in COVID19, are they really specific? / Inflammatory markers in COVID19
por: Bhattacharya, Deepanjan, et al.
Publicado: (2021)

Laparoscopic versus open gastrectomy for gastric cancer
por: Zeng, Furong, et al.
Publicado: (2020)

Pretreatment neutrophil-to-lymphocyte ratio predicts the benefit of gastric cancer patients with systemic therapy
por: Du, Songtao, et al.
Publicado: (2021)

Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2021)

The association of inflammatory markers in pregnant women with COVID-19 disease severity
por: Wei, Lili S., et al.
Publicado: (2022)

RACIAL/ETHNIC DISPARITIES ON INFLAMMATORY MARKERS IN SEVERE COVID-19 PNEUMONIA
por: GO, R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r39rt7rc2p9pjc70lsbki38mnv